Hence, mice carrying the deletion of a splicing enhancer in Plp1 intron 3, causing a mild form of PMD and reducing PLP1-specific splicing in vitro, have been developed [34]. Here, PLP1 is linked to Pelizeaus-Merzbacher spectrum disorder.